Oncogenic pathways of AML1-ETO in acute myeloid leukemia: Multifaceted manipulation of marrow maturation
- 27 November 2006
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 251 (2) , 179-186
- https://doi.org/10.1016/j.canlet.2006.10.010
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activityCancer Cell, 2006
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006
- Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic PotentialCell, 2005
- Interplay of RUNX1/MTG8 and DNA Methyltransferase 1 in Acute Myeloid LeukemiaCancer Research, 2005
- Leukemogenesis Caused by Incapacitated GATA-1 FunctionMolecular and Cellular Biology, 2004
- E Protein Silencing by the Leukemogenic AML1-ETO Fusion ProteinScience, 2004
- Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1Nature Genetics, 2004
- Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia: a study of the AML Study Group Ulm (AMLSG ULM)Blood, 2003
- Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cellsLeukemia, 2003
- The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cellsBlood, 2003